Sale!

MECP2 Gene Mental Retardation X-Linked Syndromic Lubs Type Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MECP2 Gene Mental Retardation X-Linked Syndromic Lubs Type NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MECP2 gene associated with X-linked neurological disorders. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations responsible for Lubs type syndrome, characterized by intellectual disability, developmental delays, and neurological symptoms. The test is essential for individuals showing symptoms of X-linked mental retardation, families with a history of neurological disorders, and those seeking genetic counseling for family planning. Results provide critical information for accurate diagnosis, personalized treatment planning, and genetic counseling. The test is available for $500 USD with a regular price of $700 USD, offering significant savings for comprehensive genetic analysis.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MECP2 Gene Mental Retardation X-Linked Syndromic Lubs Type NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The MECP2 Gene Mental Retardation X-Linked Syndromic Lubs Type NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for neurological conditions. This advanced test specifically targets mutations in the MECP2 gene, which plays a crucial role in brain development and function. When mutations occur in this gene, they can lead to X-linked syndromic mental retardation, also known as Lubs type syndrome, characterized by significant intellectual disability and neurological complications.

What Does This Test Measure?

This sophisticated genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the MECP2 gene for various types of mutations including:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions
  • Copy number variations
  • Structural rearrangements affecting the MECP2 gene

The MECP2 gene encodes methyl-CpG-binding protein 2, which is essential for normal neurological development and function. Mutations in this gene disrupt normal brain development and can lead to the characteristic features of X-linked syndromic mental retardation.

Who Should Consider This Test?

This genetic test is recommended for individuals displaying symptoms or having family history suggestive of X-linked neurological disorders:

  • Males with unexplained intellectual disability or developmental delays
  • Individuals with family history of X-linked mental retardation
  • Patients presenting with neurological symptoms including seizures, movement disorders, or autism spectrum features
  • Families seeking genetic counseling for family planning purposes
  • Individuals with suspected Lubs type syndrome or related neurological conditions
  • Patients with developmental regression or loss of acquired skills

Key Benefits of MECP2 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and families:

  • Accurate Diagnosis: Provides definitive genetic confirmation of MECP2-related disorders
  • Personalized Treatment Planning: Enables targeted interventions and management strategies
  • Genetic Counseling: Supports informed family planning decisions
  • Early Intervention: Facilitates timely therapeutic interventions for better outcomes
  • Family Risk Assessment: Identifies carrier status and recurrence risks for family members
  • Research Contribution: Contributes to ongoing research in neurological genetics

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of genetic specialists and neurologists:

  • Positive Result: Indicates the presence of a pathogenic mutation in the MECP2 gene, confirming the genetic basis for neurological symptoms
  • Negative Result: Suggests that MECP2 mutations are not the cause of the clinical presentation, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: For female relatives, identifies carrier status for X-linked inheritance patterns

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Details and Pricing

Test Component Details
Test Name MECP2 Gene Mental Retardation X-Linked Syndromic Lubs Type NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Neurology and Genetics

Pre-Test Requirements

Before undergoing testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session to create a detailed family pedigree
  • Discussion of testing implications and potential outcomes
  • Informed consent process

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures accessible genetic testing services for patients nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neurological symptoms affect your quality of life. Our MECP2 genetic testing provides the answers you need for informed medical decisions and personalized care planning. With our discounted price of $500 USD (regularly $700 USD), comprehensive genetic analysis is more accessible than ever.

Book your MECP2 Genetic DNA Test today by calling our genetic specialists at +1(267) 388-9828 or schedule your appointment online. Take control of your neurological health with definitive genetic insights from America’s leading genetics laboratory.